Skip to Content
MIT News magazine

Nina Tandon, SM '06

Biomedical engineer uses electrical signals to grow beating heart tissue

Nina Tandon wants to grow “spare parts” for the human body. “To my friends, I am a real-life Dr. Frankenstein,” she says.

A biomedical engineer, Tandon works at Columbia University’s Laboratory for Stem Cells and Tissue Engineering, where she uses electrical signals to direct cell growth and differentiation. The electricity mimics the natural signals that bodies produce and encourages cells to thrive in the lab. So far, Tandon has coaxed heart cells sampled from rats to develop into beating tissue, but her ultimate goal is to blaze a trail for future scientists to grow whole organs for human transplants and pharmaceutical testing.

Tandon traces her fascination with biology to childhood road trips with her family. The New York native recalls watching the passing landscape and realizing what it meant to be the only one of her siblings with unimpaired vision—her brother has retinitis pigmentosa, a degenerative eye disease, while both of her sisters are color vision deficient. “Roadside Bingo was a challenge for us,” she says. “But from that, I learned that our perceptions of the world can differ greatly from one individual to another.”

Tandon decided to learn more about the body. After earning an undergraduate degree from the Cooper Union in Manhattan in 2001, she won a Fulbright Scholarship and traveled to the University of Rome Tor Vergata in Italy to work on LibraNose, an ongoing project analyzing patient breath samples to determine the feasibility of a noninvasive cancer-smelling device.

In 2004, Tandon won an MIT Presidential Fellowship and enrolled. She spent her first semester with the Retinal Implant Research Group in honor of her brother, but it was her second rotation, spent working on the heart at the Langer Lab, that set the course for her career. After completing her SM in bioelectrical engineering, she earned an MS and PhD in biomedical engineering from Columbia University, where she is currently pursuing an MBA in parallel with her research.

Why the business degree? Tandon plans to launch a biomedical enterprise within five years. She credits MIT for her decision: “There, I learned the importance of crossing the ‘Valley of Death’—the gap in feasibility and funding between medical research and the patients who need our help. To do this, scientists need to become leaders in both research and business, building a meritocratic corporate culture.”

Away from the lab, Tandon is a certified yoga instructor. But even on her days off, research is not far from her thoughts. “Yoga teaches the philosophies of living in the moment and careful observation,” she says. “These are skills every scientist aspires to.”

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.